CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

CRISPR-based gene editing holds great promise, but off-target effects remain a major concern, especially across diverse ...

Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...

A Ph.D. graduate student in biomolecular engineering at UC Santa Cruz, with a background in computer science and mathematics, ...

Analysts have also weighed in on stock throughout the month. Recent analyst calls on the stock include: Needham analyst Gil ...

A Ph.D. student in biomolecular engineering at the University of California, Santa Cruz, has built a software program ...

CRISPR Therapeutics (NasdaqGM:CRSP) witnessed a substantial price movement, increasing 57% over the last quarter. This significant rise aligns with key developments, such as the company's inclusion in ...

UC Berkeley and Caltech researchers identified a gene circuit in zebrafish that allows heart regeneration after injury. Using ...

CRISPR will allow you to-- do many different things. You can cut it-- to edit it. Bill Whitaker: So you can snip out the bad part and you can add something that you want as well?

CRISPR, which stands for clustered regularly interspaced short palindromic repeats, is part of that bacterial immune system. "Palindromic" means any sequence that reads the same forward and backward.

UC Davis scientists spent years editing a sex-determining gene into bovine embryos using Crispr. In April, Cosmo arrived—and his DNA reveals how far the field has to go.